New wireless sensors monitor sick, premature babies without disrupting imaging exams

Courtesy of Northwestern University. 

The sensors, detailed in a study published online March 1 in Science, provide data as accurate as that from traditional, and often wire-heavy monitoring systems. They also have adhesives that are gentler on a newborn’s skin and allow for more physical bonding between the baby and parent.   

87 lots of losartan recalled as FDA investigation reveals more impurities in BP drugs

An ongoing FDA investigation of generic angiotensin II receptor blocker (ARB) drugs used to treat hypertension and heart failure found higher-than-acceptable levels of the carcinogen N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) in recent batches of losartan potassium tablets, prompting a voluntary recall of 87 lots, the agency announced March 1. NMBA is the third different carcinogenic impurity recently discovered in ARBs.